Who is sponsoring NCT06183710?

NCT06183710 is sponsored by King's College Hospital NHS Trust.

What drugs are being tested in NCT06183710?

Interventions in NCT06183710: Contingency management.

What condition does NCT06183710 study?

NCT06183710 studies Alcohol-related Liver Disease.

Is NCT06183710 still recruiting?

NCT06183710 is currently status unknown. Last updated 7 February 2024.

Last reviewed 2024-02-07 · How we verify

NCT06183710

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease

Status unknown NA Last updated 7 February 2024

What this trial tests

NA trial testing Contingency management in Alcohol-related Liver Disease in 30 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
31 December 2023

30 September 2024

Quick facts

Lead sponsor	King's College Hospital NHS Trust
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	30
Start date	1 January 2023
Primary completion	31 December 2023
Estimated completion	30 September 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Contingency management

Conditions studied

Alcohol-related Liver Disease — all drugs for Alcohol-related Liver Disease →

Sponsor

King's College Hospital NHS Trust

Who can join

18 and older, any sex, with Alcohol-related Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A sample of 30 alcohol-related liver disease patients will be recruited through consecutive sampling, facilitated through the Alcohol Care Team, which will identify potential participants to the study that have been referred to the team. Patients will be randomised either to the control or intervention group. In the control group, patients will receive outpatient integrated liver care (hepatology, psychosocial and addiction follow-ups). In the intervention group, a contingency management intervention will be delivered in addition to integrated care.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Contingency management to promote treatment engagement in comorbid alcohol use disorder and alcohol-related liver disease: Findings from a pilot randomized controlled trial.
Hemrage S, Kalk N, Shah N, Parkin S, et al · · 2025 · cited 3× · PMID 40064640 · DOI 10.1111/acer.70018
Inequity in clinical research access for service users presenting comorbidity within alcohol treatment settings: findings from a focused ethnographic study.
Hemrage S, Parkin S, Kalk NJ, Shah N, et al · · 2024 · cited 1× · PMID 38778351 · DOI 10.1186/s12939-024-02197-1
Conducting applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers
Hemrage S, Parkin S, Deluca P, Drummond C. · · 2024 · DOI 10.21203/rs.3.rs-4471569/v1
Inequity in clinical research access for service users presenting comorbidity within alcohol treatment settings: findings from a focused ethnographic study
Hemrage S, Parkin S, Kalk NJ, Shah N, et al · · 2024 · DOI 10.21203/rs.3.rs-3890867/v1

Verify or expand the search:

Other trials of Contingency management

Trials testing the same drug.

NCT06931197 — Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization · NA · not yet recruiting
NCT06688539 — E-cigarette Cessation in Adults Who Co-use Cannabis · Phase 4 · recruiting
NCT06239350 — Young Adult Tobacco/Nicotine and Cannabis Co-use · NA · recruiting
NCT06134882 — OUD Smartphone Services · NA · active not recruiting
NCT06564792 — Contingency Management in HIV Care for Both Stimulant Use & ART Adherence · NA · completed

Other recruiting trials for Alcohol-related Liver Disease

Currently open trials in the same condition.

NCT06305624 — Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease · NA · recruiting
NCT06403332 — Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal A · NA · recruiting

Other King's College Hospital NHS Trust trials

Trials by the same sponsor.

NCT07384884 — Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas · NA · not yet recruiting
NCT07379723 — Brief Intervention for FCD: A Feasibility Study · NA · recruiting
NCT07062731 — Pelvic Floor Exercises for Suboptimal Anorectal Manometry · recruiting
NCT06766162 — Virtual Reality to Improve Patient Experience During Endoscopic Mucosal and Submucosal Resection · NA · completed
NCT06918756 — Development of a Cough Control Questionnaire (CCQ) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06183710 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King's College Hospital NHS Trust
Last refreshed: 7 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06183710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing